All articles by Margaret Labban

• 

  California’s Medicaid pharmacy “carve-out” set to boost state’s negotiating power, introduce IRP for drugs

  California is planning a major overhaul of its Medicaid Pharmacy benefit, called Medi-Cal Rx, that will result in a "carve-out"…

• 

  Vaccine trade becomes a key factor in global diplomacy

  The highly transmissible COVID-19 Delta variant highlights the importance of vaccines to both health and economic recovery, with widespread vaccination…

• 

  Canada’s PMPRB reform delays add uncertainty

  The government of Canada has once again decided to delay the implementation of the major drug pricing reforms that were…

• 

  Northern Ireland: A case study for drug pricing controls vs free pricing

  Generic drug manufacturers have warned that up to 90% of drugs currently supplied to Northern Ireland may be threatened with withdrawal as…

• 

  Reference pricing in CEE countries puts downward pressure on prices

  Pharmaceutical prices in central and eastern European (CEE) countries tend to be low and drop over time - a double…